KEVIN BRIGLE: Open Payments
NPI 1912081571 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,084 in 49 payments from 8 companies in 2025. Trend: 2023 $41,968 · 2024 $36,051 · 2025 $26,084
Speaker / faculty: $10,041Consulting: $6,946Travel & lodging: $3,345Grant: $2,171Honoraria: $2,000Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $6,665 |
| Janssen Biotech, Inc. | 8 | $6,135 |
| GENZYME CORPORATION | 7 | $3,951 |
| E.R. Squibb & Sons, L.L.C. | 9 | $3,700 |
| Legend Biotech USA Inc. | 8 | $2,559 |
| Karyopharm Therapeutics Inc. | 4 | $2,240 |
| AstraZeneca Pharmaceuticals LP | 3 | $593 |
| Janssen Scientific Affairs, LLC | 2 | $240 |
Products named: DARZALEX, REBLOZYL, XPOVIO, SARCLISA, ELREXFIO, CALQUENCE, RYBREVANT, CARVYKTI.
Industry payments across VA — which companies pay providers there.
